http://feeds.feedburner.com/accpodcast Adolph M. Hutter, Jr., MD http://www.conversations.acc.org American College of Cardiology presents Conversations with Experts, a series of 20-minute interactive discussions between though-leaders on topics of importance to the medical community American College of Cardiology presents Conversations with Experts, a series of 20-minute interactive discussions between though-leaders on topics of importance to the medical community Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology en-us C 2005 American College of Cardiology ACC Conversations webmaster@acc.org Adolph M. Hutter, Jr., MD Cardiovascular Risk in Post-Bariatric Surgical Patients In this conversation, Dr. Dolph Hutter discusses the cardiovascular effects of bariatric surgery and also patient selection criteria with Dr. Mary Ann McLaughlin of the Mount Sinai School of Medicine in New York, New York, and Dr. Howard Willens of the University of Miami Miller School of Medicine in Miami, Florida. http://www.healthology.biz/acc/podcast/aac_postbariatric_pats.mp3 Tue, 5 February 2008 16:00:00 EST 12:55 Dr. Dolph Hutter, cardiovascular effects of bariatric surgery, Dr. Mary Ann McLaughlin, Mount Sinai School of Medicine, New York, New York, Dr. Howard Willens, University of Miami Miller School of Medicine, Miami, Florida. Adolph M. Hutter, Jr., MD Role of the Cardiologist in the Management of the Morbidly Obese Patient In this conversation, Dr. Dolph Hutter discusses weight loss strategies and the clinical impact of significant weigh loss in obese patients with Dr. James de Lemos and Dr. Howard Willens. http://www.healthology.biz/acc/podcast/acc_role_cardio_obese.mp3 Mon, 4 February 2008 16:00:00 EST 13:05 Dr. Dolph Hutter, weight loss strategies, Dr. James de Lemos of the University of Texas, Southwestern Medical School in Dallas, Texas and Dr. Howard Willens, of the University of Miami Miller School of Medicine in Miami, Florida Adolph M. Hutter, Jr., MD Antithrombotic Choices for Acute Coronary Syndrome Patients Undergoing Invasive Procedures A discussion on Antithrombotic Choices for Acute Coronary Syndrome Patients Undergoing Invasive Procedures http://www.healthology.biz/acc/podcast/acc_antithrombotic_invasive.mp3 Tue, 14 August 2007 16:00:00 EST 12:31 discussion, Antithrombotic Choices, Acute Coronary Syndrome, Patients, Undergoing, Invasive Procedures Adolph M. Hutter, Jr., MD Timing of Glycoprotein IIb/IIIa Inhibitor Use in ACS Patients Undergoing Invasive Procedures A discussion on Timing of Glycoprotein IIb/IIIa Inhibitor Use in ACS Patients Undergoing Invasive Procedures http://www.healthology.biz/acc/podcast/acc_antithrombotic_choices.mp3 Tue, 7 August 2007 16:00:00 EST 10:55 Timing of Glycoprotein IIb/IIIa, Inhibitor, Use in ACS, Invasive Procedures, dolph hutter Adolph M. Hutter, Jr., MD Update on the ExTRACT-TIMI Data (07/2007) New data from three subgroup analyses of "Enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction .. http://www.healthology.biz/acc/podcast/acc_update_timi.mp3 Tue, 31 July 2007 16:00:00 EST 15:55 ACC, Thrombosis, Drug-Eluting Stents, guidelines, dolph hutter Adolph M. Hutter, Jr., MD Early Initiation of Statin Therapy in Acute Coronary Syndromes (07/2007) A discussion on Early Initiation of Statin Therapy in Acute Coronary Syndromes .. http://www.healthology.biz/acc/podcast/acc_targetldl.mp3 Tue, 31 July 2007 16:00:00 EST 13:18 ACC, Early Initiation of Statin Therapy in Acute Coronary Syndromes Adolph M. Hutter, Jr., MD Preventing Late Thrombosis of Drug-Eluting Stents The risk of thrombosis after implantation of drug-eluting stents (DES) persists for a year or more. In contrast, similar risk after implantation of a bare metal stent (BMS) seems .. http://www.healthology.biz/acc/podcast/acc_prevent_thrombosis.mp3 Tue, 19 June 2007 16:00:00 EST 14:55 ACC, Thrombosis, Drug-Eluting Stents, guidelines, dolph hutter Adolph M. Hutter, Jr., MD Targeting LDL Cholesterol: Intensive Statin Treatment or Combination Therapy Ideally, the target LDL cholesterol (LDL-C) level for healthy patients is less than 100 mg/dL... http://www.healthology.biz/acc/podcast/acc_target_ldl_statin.mp3 Tue, 12 June 2007 16:00:00 EST 12:55 ACC, LDL, Intensive Statin Treatment, Combination Therapy, guidelines, dolph hutter Adolph M. Hutter, Jr., MD The Rosiglitazone Story: Does the Science Warrant the Attention Thiazolidinedione drugs are widely prescribed for lowering blood glucose in patients with type 2 diabetes. http://www.healthology.biz/acc/podcast/acc_avandia.mp3 Tue, 5 June 2007 16:00:00 EST 21:55 ACC, AHA, Rosiglitazone, Science Warrant, guidelines, dolph hutter Adolph M. Hutter, Jr., MD Effective Management of Acute Coronary Syndrome in the Elderly Effective Management of Acute Coronary Syndrome in the Elderly http://www.healthology.biz/acc/podcast/acc_manage_acs_elderly.mp3 Tue, 8 May 2007 16:00:00 EST 15:35 ACC, Elderly, Effective Management,Acute Coronary Syndrome, guidelines, dolph hutter Adolph M. Hutter, Jr., MD Pleiotropic Effects of Statins Lipid altering agents encompass several classes of drugs, including the most widely used HMG CoA reductase (hydroxymethylglutaryl CoA reductase) inhibitors or statins. http://www.healthology.biz/acc/podcast/acc_highdose_statins.mp3 Tue, 6 February 2007 16:00:00 EST 17:05 ACC, Statins, Pleiotropic Effects, guidelines, dolph hutter Adolph M. Hutter, Jr., MD The ACC/AHA Guidelines Update on Secondary Prevention Since the original publication (1995) of the AHA/ACC consensus statement on secondary prevention, key evidence from clinical trials illustrating the need for aggressive risk factor management led to a revision in 2001. Recently, the AHA/ACC guidelines have been revised once again to reflect important clinical trial evidence that further support aggressive risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease. Joining this conversation to discuss the new guidelines and their potential impact on clinical practice are Dr Sidney Smith and Dr Robert Bonow, both authors on the AHA/ACC guideline and experts in primary and secondary prevention of cardiovascular disease http://www.healthology.biz/acc/podcast/merck/acc_aha_guidelines.mp3 Tue, 9 Jan 2007 16:00:00 EST 18:55 ACC, AHA, prevention, secondary prevention, guidelines, dolph hutter http://www.healthology.biz/acc/podcast/acc_statins.mp3 Adolph M. Hutter, Jr., MD The Role of Statins in Heart Failure Several studies have reported improvement in overall outcomes in HF patients treated with statins. The possible mechanisms of benefit, other than treatment of coronary disease that may have been unrecognized, are not known. Joining this conversation to discuss the benefits and possible mechanisms of statin use in patients with heart failure are Dr Steven Nissen, specialist in atherosclerosis and current President of the ACC, and Dr Benjamin Scirica and Dr Marc Pfeffer, both clinical trialists in heart failure. http://www.healthology.biz/acc/podcast/acc_statins.mp3 Tue, 19 Dec 2006 16:00:00 EST 19:04 ischemic, non-ischemic, etiologies, heart failure, LDL, endpoints, TNT http://www.healthology.biz/acc/podcast/acc_update_acc.mp3 Adolph M. Hutter, Jr., MD Updates to the Manage of Acute Coronary Syndrome: ExTRACT-TIMI 25 Subgroup Analysis Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardial infarction. ExTRACT-TIMI 25 compared a low-molecular-weight heparin, enoxaparin, with unfractionated heparin for this purpose. http://www.healthology.biz/acc/podcast/acc_update_acc.mp3 Tue, 12 Dec 2006 16:00:00 EST 12:40 Acute Coronary Syndrome, TIMI 25, ExTRACT, heparin, enoxaparin http://www.healthology.biz/acc/podcast/acc_arterialstiffness.mp3 Adolph M. Hutter, Jr., MD What is the Relevance of Pulse Pressure and Arterial Stiffness? Pulse pressure is defined as the systolic minus the diastolic pressure. This value appears, at least in some epidemiologic studies, to be superior in predictive value to the systolic or diastolic values alone. http://www.healthology.biz/acc/podcast/acc_arterialstiffness.mp3 Tue, 5 Dec 2006 16:00:00 EST 15:30 Pulse, Pressure, Arterial, Stiffness http://www.healthology.biz/acc/podcast/acc_treat_options.mp3 Adolph M. Hutter, Jr., MD Treatment Options for the Stage C Heart Failure Patient According to the ACC/AHA guideline for the diagnosis and management of chronic heart failure, stage C includes patients with structural heart disease and symptomatic heart failure.Joining this conversation to discuss the current treatment options for patients who have stage C heart failure are Dr. Lynne Stevenson, Dr. Marvin Konstam, and Dr. Marc Semigran, all clinical cardiologists and experts in the treatment of heart failure. http://www.healthology.biz/acc/podcast/acc_treat_options.mp3 Tue, 26 Sep 2006 16:00:00 EST 26:04 Stage c heart failure, dolph hutter, ACEIs or ARBs and beta-blockers http://www.healthology.biz/acc/podcast/personalizing_cardio.mp3 Adolph M. Hutter, Jr., MD Personalizing Cardiovascular Medicine Based on Different Patient Populations A discussion of the challenges to understanding racial/ethnic differences in cardiovascular risk factors and treatment outcomes. http://www.healthology.biz/acc/podcast/personalizing_cardio.mp3 Tue, 19 Sep 2006 16:00:00 EST 12:10 Cardiovascular medicine, patient populations, dolph hutter, Christopher o'donnell. http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_nstem.mp3 Adolph M. Hutter, Jr., MD Update on UA/NSTEMI Management Update on UA/NSTEMI Management http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_nstem.mp3 Tue, 9 May 2006 12:00:00 EST 16:29 http://www.healthology.biz/acc/podcast/novartis/acc_conv_ras.mp3 Adolph M. Hutter, Jr., MD Current Approaches to RAS Blockade Current Approaches to RAS Blockade http://www.healthology.biz/acc/podcast/novartis/acc_conv_ras.mp3 Tue, 2 May 2006 12:00:00 EST 16:50 http://www.healthology.biz/acc/podcast/medcompany/acc_conv_adest.mp3 Adolph M. Hutter, Jr., MD Drug Eluting Stents and Bivalirudin: Data from ADEST and Other PCI Trials Drug Eluting Stents and Bivalirudin: Data from ADEST and Other PCI Trials http://www.healthology.biz/acc/podcast/medcompany/acc_conv_adest.mp3 Tue, 25 Apr 2006 12:00:00 EST 13:33 http://www.healthology.biz/acc/podcast/medcompany/acc_thrombin.mp3 Adolph M. Hutter, Jr., MD Role of Direct Thrombin Inhibitors in ACS Role of Direct Thrombin Inhibitors in ACS http://www.healthology.biz/acc/podcast/medcompany/acc_thrombin.mp3 Tue, 18 Apr 2006 12:00:00 EST 14:20 http://www.healthology.biz/acc/podcast/medcompany/acc_conv_hit.mp3 Adolph M. Hutter, Jr., MD Pathogenesis, Diagnosis, Treatment and Prevention of Heparin-induced Thrombocytopenia Pathogenesis, Diagnosis, Treatment and Prevention of Heparin-induced Thrombocytopenia http://www.healthology.biz/acc/podcast/medcompany/acc_conv_hit.mp3 Tue, 11 Apr 2006 12:00:00 EST 20:45 http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_extract.mp3 Adolph M. Hutter, Jr., MD ExTRACT TIMI-25 ExTRACT TIMI-25 http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_extract.mp33 Tue, 4 Apr 2006 12:00:00 EST 15:27 http://www.healthology.biz/acc/podcast/medcompany/acc_conv_acuity.mp3 Adolph M. Hutter, Jr., MD ACUITY Trial: Heparins Vs. Bivalirudin for ACS ACUITY Trial: Heparins Vs. Bivalirudin for ACS http://www.healthology.biz/acc/podcast/medcompany/acc_conv_acuity.mp3 Tue, 14 Mar 2006 12:00:00 EST 11:35 http://www.healthology.biz/acc/podcast/acc_conv_bnp.mp3 Adolph M. Hutter, Jr., MD BNP: Understanding Its Clinical Utility BNP: Understanding Its Clinical Utility http://www.healthology.biz/acc/podcast/acc_conv_bnp.mp3 Tue, 20 Dec 2005 12:00:00 EST 19:20 http://www.healthology.biz/acc/podcast/biosite/acc_multimarkers_conv.mp3 Adolph M. Hutter, Jr., MD Multi-Markers Strategies for the Rapid Diagnosis of ACS Multi-Markers Strategies for the Rapid Diagnosis of ACS http://www.healthology.biz/acc/podcast/biosite/acc_multimarkers_conv.mp3 Tue, 13 Dec 2005 12:00:00 EST 19:20 http://www.healthology.biz/acc/podcast/acc_betablockers.mp3 Adolph M. Hutter, Jr., MD Should Beta-Blockers be First-Line Therapy in Primary Hypertension? Should Beta-Blockers be First-Line Therapy in Primary Hypertension? http://www.healthology.biz/acc/podcast/acc_betablockers.mp3 Tue, 6 Dec 2005 12:00:00 EST 15:06 http://www.healthology.biz/acc/podcast/novartis/acc_ab_progression.mp3 Adolph M. Hutter, Jr., MD Stages A & B Pre-HF: Identification and Prevention of Progression Stages A & B Pre-HF: Identification and Prevention of Progression http://www.healthology.biz/acc/podcast/novartis/acc_ab_progression.mp3 Tue, 6 Dec 2005 12:00:00 EST 18:47 http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_steeple.mp3 Adolph M. Hutter, Jr., MD STEEPLE Trial: Enoxaparin Vs. UFH for Non-emergent PCI STEEPLE Trial: Enoxaparin Vs. UFH for Non-emergent PCI http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_steeple.mp3 Tue, 22 Nov 2005 12:00:00 EST 14:30 http://www.healthology.biz/acc/podcast/novartis/acc_renin_benifits.mp3 Adolph M. Hutter, Jr., MD Potential Benefits with Renin Inhibitors Joining this conversation to discuss the current data and potential outlook of renin inhibitors are Dr. Haralambos Gavras and Dr. Michael Weber, both thought leaders in hypertension and cardiovascular disease. http://www.healthology.biz/acc/podcast/novartis/acc_renin_benifits.mp3 Tue, 10 Oct 2006 12:00:00 EST 14:22 renin-angiotensin, vascular, Inhibitors, renin, angiotensin, AT2 http://www.healthology.biz/acc/podcast/pfizer/acc_chronicpain_pfiz1.mp3 Adolph M. Hutter, Jr., MD Effectively Managing Non-Cardiac Chronic Pain in Patients at Risk for Cardiovascular Disease Effectively Managing Non-Cardiac Chronic Pain in Patients at Risk for Cardiovascular Disease http://www.healthology.biz/acc/podcast/pfizer/acc_chronicpain_pfiz1.mp3 Tue, 6 Sep 2005 12:00:00 EST 7:00 Non-cardiac chronic pain, non-steroidal anti-inflammatory drugs, NSAID's, Dr. Dwight Robinson, BruceChronstein, manage patients, clinical role of COX-2 inhibitors, antiplatelet effects, aspirin, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_stemi_av.mp3 Adolph M. Hutter, Jr., MD ACC/AHA STEMI Guidelines: Judging Time and Choosing Reperfusion Methods ACC/AHA STEMI Guidelines: Judging Time and Choosing Reperfusion Methods http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_stemi_av.mp3 Tue, 23 Aug 2005 12:00:00 EST 7:00 AHA, STEMI Guidelines, Sidney Smith, MD, Deepak Bhatt, MD, STEMI Patients, Pharmacological and mechanical reperfusion strategies, Fibrinolysis, primary PCI, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/bayer/acc_womenhealth_bhc.mp3 Adolph M. Hutter, Jr., MD The Women's Health Study: What's the Correct Dose of Aspirin for Prevention of CV Disease The Women's Health Study: What's the Correct Dose of Aspirin for Prevention of CV Disease http://www.healthology.biz/acc/podcast/bayer/acc_womenhealth_bhc.mp3 Tue, 16 Aug 2005 12:00:00 EST 7:00 Women and Heart Disease, The Women's Health Study, Correct Dose of Aspirin, Aspirin, Preventing Cardiovascular Disease, Cardiovascular Disease in Women, Sidney Smith, MD, Michael Gaziano, MD, non-fatal myocardial infarction, nonfatal stroke, low-dose aspirin, WHS, effectively administering aspirin, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/novartis/acc_valiant_nv.mp3 Adolph M. Hutter, Jr., MD Reviewing Data from the VALIENT Trial Reviewing Data from the VALIENT Trial http://www.healthology.biz/acc/podcast/novartis/acc_valiant_nv.mp3 Tue, 9 Aug 2005 12:00:00 EST 7:00 VALIENT Trial, sudden death, acute myocardial infarction, reduced left ventricular systolic function, VALsartan In Acute Myocardial Infarction, high-risk patients, angiotensin II receptor blocker, ARB, post-MI, Jay Cohn, MD, Scott Solomon, ACE inhibitors, ARB's in patients, LVD, HF, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/acc_dietcardio.mp3 Adolph M. Hutter, Jr., MD Evaluating several dietary approached and the scientific data relating to cardiovascular health Evaluating several dietary approached and the scientific data relating to cardiovascular health http://www.healthology.biz/acc/podcast/acc_dietcardio.mp Wed, 25 May 2005 12:00:00 EST 7:00 Diet and heart health, heart health, Cardiovascular disease, Laurence Sperling, MD, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/acc_lipid_therapy.mp3 Adolph M. Hutter, Jr., MD Discussing the features of a vulnerable plaque as seen by MRI and the site-specific differences of atherosclerotic plaques Discussing the features of a vulnerable plaque as seen by MRI and the site-specific differences of atherosclerotic plaques http://www.healthology.biz/acc/podcast/acc_lipid_therapy.mp3 Mon, 14 Aug 2006 12:00:00 EST 7:00 atherosclerotic plaques, MRI, Thoracic aortic plaque regression, lipid-lowering therapy with simvastatin, atorvastatin, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/pfizer/acc_painmeds_pfiz.mp3 Adolph M. Hutter, Jr., MD The Cardiovascular Risk of COX-2 Inhibitors and Other NSAIDs: Reviewing the FDA Advisory Panel Methods, Data and Conclusions The Cardiovascular Risk of COX-2 Inhibitors and Other NSAIDs: Reviewing the FDA Advisory Panel Methods, Data and Conclusions http://www.healthology.biz/acc/podcast/pfizer/acc_painmeds_pfiz.mp3 Mon, 14 Aug 2006 12:00:00 EST 7:00 COX-2 Inhibitors, NSAIDs, Arthritis and Drug Safety, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3 Adolph M. Hutter, Jr., MD Discussion on why metroprolol tartrate was used at a dose of 50 mg bid and its importance when interpreting data from the COMET trial and the comparison data on myocardial and metabolic effects. Discussion on why metroprolol tartrate was used at a dose of 50 mg bid and its importance when interpreting data from the COMET trial and the comparison data on myocardial and metabolic effects. http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3 Mon, 30 Mar 2005 12:00:00 EST 7:00 COMET Trial, myocardial and metabolic effects, metroprolol tartate, carvedilol and metoprolol, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_synergy_av.mp3 Adolph M. Hutter, Jr., MD SYNERGY: Analyzing New Data from This 10,000-Patient Trial SYNERGY: Analyzing New Data from This 10,000-Patient Trial http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_synergy_av.mp3 Mon, Mar 23 2005 12:00:00 EST 7:00 SYNERGY Trial, enoxaparin, acute coronary syndrome, NSTE-ACS, antithrombin therapy, treating NSTE-ACS patients, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/pfizer/acc_conv_clinical_pfiz.mp3 Adolph M. Hutter, Jr., MD The Clinical Importance of Left Ventricular Mass in Hypertension The Clinical Importance of Left Ventricular Mass in Hypertension http://www.healthology.biz/acc/podcast/pfizer/acc_conv_clinical_pfiz.mp3 Mon, 14 Aug 2006 12:00:00 EST 7:00 Hypertention, Left-ventricular mass in hypertension, lV Mass, optimve use of echocardiography, LV Measurements, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/abbott/acc_antihyperdi_ab.mp3 Adolph M. Hutter, Jr., MD The Effects of Anti-hypertensives in New-onset Diabetes The Effects of Anti-hypertensives in New-onset Diabetes http://www.healthology.biz/acc/podcast/abbott/acc_antihyperdi_ab.mp3 Mon, 14 Aug 2006 12:00:00 EST 7:00 Anti-hypertensives, diabetes, diabetes onset, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/acc_aheft.mp3 Adolph M. Hutter, Jr., MD Brief summary of the major findings and clinical conclusions from A-HeFT Brief summary of the major findings and clinical conclusions from A-HeFT http://www.healthology.biz/acc/podcast/acc_aheft.mp3 Mon, 14 Aug 2006 12:00:00 EST 7:00 A-HeFT, Heart Failure, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3 Adolph M. Hutter, Jr., MD The GEMINI Trial: Comparing the Glycemic Effects of Carvedilol and Metoprolol in Hypertensive Patients with Diabetes The GEMINI Trial: Comparing the Glycemic Effects of Carvedilol and Metoprolol in Hypertensive Patients with Diabetes http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3 Mon, 14 Aug 2006 12:00:00 EST 7:00 GEMINI Trial, Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives, Beta-Blockers, glycemic and metabolic control, Type II diabetes, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology http://www.healthology.biz/acc/podcast/aventis/acc_treatnstemi_av.mp3 Adolph M. Hutter, Jr., MD Treating NSTEMI When Emergency PCI is Not and Option Treating NSTEMI When Emergency PCI is Not and Option http://www.healthology.biz/acc/podcast/aventis/acc_treatnstemi_av.mp3 Mon, 14 Aug 2006 12:00:00 EST 7:00 ACS, ACS patients, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology